Product Information
Human
Cell death can occur due to a variety of circumstances including nutrient deprivation, inability to generate or store the energy required for metabolic functions, or deleterious environment that causes irreparable damage. Cells integrate multiple signals from a variety of sources before following either pro- or anti-apoptotic pathways. These signals can often carry conflicting information. Assessing the net effect of these processes in cell populations can be achieved by monitoring changes in a number of key signaling components. The caspase-3 and caspase-7 proteases exert a pro-apoptotic function through cleavage of multiple cellular targets. Caspase-3 and caspase-7 are activated by cleavage at Asp175 and Asp198, respectively. PARP is a DNA repair and apoptosis enzyme that is inactivated by cleavage at Asp214 by caspase-3 or caspase-7. HSP27 is a mediator of cell stress that confers resistance to adverse environmental conditions. HSP27 is activated by phosphorylation at Ser82. Chk1 and Chk2 kinases act downstream of ATM/ATR and play an important role in DNA damage checkpoint control. Activation of Chk1 and Chk2 involve phosphorylation at Ser345 and Thr68, respectively. Tumor suppressor p53 plays an important role in cellular response to DNA damage. p53 is phosphorylated at Ser15 by ATM/ATR or DNA-PK leading to its accumulation. Smad2 is a key mediator of TGF-β signaling. Stimulation by TGF-β leads to Smad2 phosphorylation at Ser465/467 and translocation of Smad2 into the nucleus. The outcome of TGF-β signaling is context dependent and can either induce apoptosis or contribute to tumor cell metastasis. Activation of NF-κB/Rel occurs through a proteasome-mediated degradation of IκBα. The inhibitor IκBα is targeted to the proteasome via phosphorylation of IκBα at Ser32 and Ser36. NF-κB activation is triggered by a diverse group of extracellular signals promoted by inflammatory cytokines, growth factors, and chemokines. TAK1 is a kinase that can be activated by TGF-β, bone morphogenetic proteins and other cytokines. Activated TAK1 phosphorylates MKK4, MKK3/6, and NIK. Phosphorylation of TAK1 at Ser412 is one of the mechanisms that regulate the levels of its activation. Cellular stress such as viral infection, endoplasmic reticulum stress, and amino acid deprivation leads to phosphorylation of eIF2α. Phosphorylation of eIF2α at Ser51 in response to cellular stress leads to a reduction of protein synthesis. The ERK1 and ERK2 MAP kinases are major signaling nodes that have many substrates and primarily transmit growth and proliferation signals. The ERK MAP kinase is activated by a dual phosphorylation of Thr202 and Tyr204. p38 MAPK and SAPK/JNK MAP kinases are activated through a similar dual phosphorylation mechanism in response to pro-inflammatory cytokines and genotoxic stress. Akt is activated by stimulation of growth-factor receptors and primarily promotes anabolic growth and survival signals via targeting its broad array of substrates. Akt phosphorylates Bad at Ser136 and inhibits its ability to induce apoptosis. Survivin is an anti-apoptotic protein that is highly expressed during fetal development and cancer cell malignancy. Survivin binds and inhibits caspase-3, controlling the cell cycle by inhibiting apoptosis and promoting cell division. α-tubulin is a building block of microtubules that are present in all eukaryotic cells. The levels of the globular α-tubulin are considered to remain relatively constant. Therefore, assessing the relative levels of α-tubulin may assist with signal normalization between the various samples.
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.